Severe Acute Respiratory Syndrome (veterinary) < Severe Acute Respiratory Syndrome (virology) < Severity of Illness Index

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000A58 (2013)	Anna Petherick	MERS-CoV: in search of answers
000A72 (2013)	K. L. Hon	Severe respiratory syndromes: Travel history matters
000A90 (2013)	Jean-Yves Nau	[Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
000A91 (2013)	Jasper Fuk-Woo Chan [République populaire de Chine] ; Susanna Kar-Pui Lau [République populaire de Chine] ; Patrick Chiu-Yat Woo [République populaire de Chine]	The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”
000B07 (2013)	Elizabeth Devitt	Lack of small animal model hinders MERS coronavirus research
000B39 (2013)	Hisham Momattin [Arabie saoudite] ; Khurram Mohammed [Arabie saoudite] ; Alimuddin Zumla [Royaume-Uni] ; Ziad A. Memish [Arabie saoudite] ; Jaffar A. Al-Tawfiq [États-Unis]	Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
000B40 (2013)	Fang Li	Receptor recognition and cross-species infections of SARS coronavirus
000B44 (2013)	Rolf Hilgenfeld [Allemagne] ; Malik Peiris [République populaire de Chine]	From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
000B47 (2013)	Daniela Niemeyer [Allemagne] ; Thomas Zillinger ; Doreen Muth ; Florian Zielecki ; Gabor Horvath ; Tasnim Suliman ; Winfried Barchet ; Friedemann Weber ; Christian Drosten ; Marcel A. Müller	Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist.
000B52 (2013)	Trevor Scobey [États-Unis] ; Boyd L. Yount ; Amy C. Sims ; Eric F. Donaldson ; Sudhakar S. Agnihothram ; Vineet D. Menachery ; Rachel L. Graham ; Jesica Swanstrom ; Peter F. Bove ; Jeeho D. Kim ; Sonia Grego ; Scott H. Randell ; Ralph S. Baric	Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.
000B59 (2013)	Emmie De Wit [États-Unis] ; Angela L. Rasmussen ; Darryl Falzarano ; Trenton Bushmaker ; Friederike Feldmann ; Douglas L. Brining ; Elizabeth R. Fischer ; Cynthia Martellaro ; Atsushi Okumura ; Jean Chang ; Dana Scott ; Arndt G. Benecke ; Michael G. Katze ; Heinz Feldmann ; Vincent J. Munster	Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.
000B70 (2013)	Mark Turlington [États-Unis] ; Aspen Chun ; Sakshi Tomar ; Aimee Eggler ; Valerie Grum-Tokars ; Jon Jacobs ; J Scott Daniels ; Eric Dawson ; Adrian Saldanha ; Peter Chase ; Yahira M. Baez-Santos ; Craig W. Lindsley ; Peter Hodder ; Andrew D. Mesecar ; Shaun R. Stauffer	Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding.
000B71 (2013)	N. Van Doremalen [États-Unis] ; T. Bushmaker ; V J Munster	Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions.
000B78 (2013)	Graham Simmons [États-Unis] ; Pawel Zmora [Allemagne] ; Stefanie Gierer [Allemagne] ; Adeline Heurich [Allemagne] ; Stefan Pöhlmann [Allemagne]	Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
000B91 (2013)	Sami Al Hajjar [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] ; Kenneth Mcintosh [États-Unis]	Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Perpetual Challenge
000C05 (2013)	Lászl R Kusz ; István Jankovics ; Máté Jankovics ; Júlia Sarkadi ; Ildik Visontai	[Importance of the case of coronavirus-associated severe acute respiratory syndrome detected in Hungary in 2005].
000C73 (2014)	Vineet D. Menachery [États-Unis] ; Boyd L. Yount ; Laurence Josset ; Lisa E. Gralinski ; Trevor Scobey ; Sudhakar Agnihothram ; Michael G. Katze ; Ralph S. Baric	Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
000C84 (2014)	Halil Aydin [Canada] ; Dina Al-Khooly ; Jeffrey E. Lee	Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: insights into mechanisms of general viral fusion and inhibitor design.
000D03 (2014)	Jaffar A. Al-Tawfiq [Arabie saoudite] ; Ziad A. Memish	What are our pharmacotherapeutic options for MERS-CoV?
000D50 (2014)	Kai Kupferschmidt	Emerging diseases. Soaring MERS cases in Saudi Arabia raise alarms.
000E34 (2014)	David R. Strayer ; Robert Dickey ; William A. Carter [États-Unis]	Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Severe Acute Respiratory Syndrome (virology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Severe Acute Respiratory Syndrome (virology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Severe Acute Respiratory Syndrome (virology)
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021